Oncogenic RAS Enables DNA Damage- and p53-Dependent Differentiation of Acute Myeloid Leukemia Cells in Response to Chemotherapy

Mona Meyer, Daniela Rübsamen, Robert Slany et al. · 2009

Read Oncogenic RAS Enables DNA Damage- and p53-Dependent Differentiation of Acute Myeloid Leukemia Cells in Response to Chemotherapy by Mona Meyer, Daniela Rübsamen, Robert Slany et al. (2009) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0007768.txt.

Description

Mona Meyer and co-authors published a study in PLOS ONE in 2009. It reports a surprise effect of a cancer gene in leukemia cells. Acute myeloid leukemia starts in blood-forming progenitor cells with varied genetics. Mutations in the RAS gene are frequent in this disease.

Standard chemotherapy uses high-dose cytarabine. The team found that oncogenic RAS lets leukemia cells respond to chemotherapy in an unusual way. With DNA damage and the protein p53 present, the cells differentiate instead of just dying. Forcing cancer cells to mature is a known treatment idea. This work shows one path by which it can happen.

Catalog record

CREATORMona Meyer, Daniela Rübsamen, Robert Slany et al.
YEAR2009
COLLECTIONPAPERS
FORMATTXT
FILE SIZE68 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0007768

Browse the full library · About the Tower of Babel